WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

New weight-loss pill ‘better than jabs’

Those taking amycretin lost almost a quarter of their body weight in 36 weeks, the best result yet for a GLP drug

Raccontata datelegraph.co.ukft.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
telegraph.co.ukStai leggendo1 anni fa

New weight-loss pill ‘better than jabs’

Those taking amycretin lost almost a quarter of their body weight in 36 weeks, the best result yet for a GLP drug

originale
ft.com1 anni fa

New Novo Nordisk drug could beat market leaders for weight loss, early results show

Participants in trial of amycretin injectable obesity drug lost an average of 24% of their body weight on highest dose

Leggi questa versione → originale

Timeline cronologica

  1. venerdì 20 giugno 2025·telegraph.co.uk

    New weight-loss pill ‘better than jabs’

    Those taking amycretin lost almost a quarter of their body weight in 36 weeks, the best result yet for a GLP drug

  2. sabato 21 giugno 2025·ft.com

    New Novo Nordisk drug could beat market leaders for weight loss, early results show

    Participants in trial of amycretin injectable obesity drug lost an average of 24% of their body weight on highest dose